文献速递儿童呼吸

地塞米松与泼尼松治疗儿童急性哮喘发作的随机试验

Randomized Trial of Dexamethasone Versus Prednisone for Children with Acute Asthma Exacerbations.
PubMed 文献 · J Pediatr · 2017-01-01

这项随机非劣效性试验纳入1-14岁急诊急性哮喘患儿,比较2剂地塞米松(0.6 mg/kg/剂)与5天泼尼松/泼尼松龙疗程(1.5 mg/kg/d,第2-5天1 mg/kg/d)的疗效。第7天症状持续率、生活质量评分、入院率、非计划急诊复诊及呕吐率两组均无显著差异,地塞米松组依从性更高(99.3% vs 96.0%,P < .05)。

要点

  • 2剂地塞米松与5天泼尼松/泼尼松龙在改善第7天症状和生活质量上无显著差异。
  • 两组入院率、非计划急诊复诊及呕吐率均无显著差异。
  • 地塞米松组依从性显著高于泼尼松/泼尼松龙组(P < .05)。

核心结论

  • 2剂地塞米松可能是5天泼尼松/泼尼松龙疗程的有效替代方案,依据为第7天症状持续性和生活质量。

研究设计与样本

  • 随机、非劣效性试验,纳入1-14岁因急性哮喘就诊急诊的患儿,共590名同意参与,557名有主要结局数据。

主要发现

  • 第7天症状持续率:地塞米松组56.6%(95%CI 50.6-62.6),泼尼松/泼尼松龙组58.3%(95%CI 52.3-64.2),无差异。
  • 第7天生活质量评分:地塞米松组80.0,泼尼松/泼尼松龙组77.7,无显著差异。
  • 入院率:地塞米松组23.9%,泼尼松/泼尼松龙组21.7%,无显著差异。
  • 非计划急诊复诊率:地塞米松组4.6%,泼尼松/泼尼松龙组3.3%,无显著差异。
  • 呕吐率:地塞米松组2.1%,泼尼松/泼尼松龙组4.4%,无显著差异;依从性地塞米松组99.3% vs 96.0%,P < .05。

关键数值与推荐

  • 地塞米松方案:0.6 mg/kg/剂,共2剂。
  • 泼尼松/泼尼松龙方案:1.5 mg/kg/d,第2-5天1 mg/kg/d,共5天。

临床怎么用

  • 对于急诊急性哮喘发作的1-14岁患儿,可考虑使用2剂地塞米松替代5天泼尼松/泼尼松龙疗程。
  • 地塞米松方案可能提高治疗依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether 2 doses of dexamethasone is as effective as 5 days of prednisolone/prednisone therapy in improving symptoms and quality of life of children with asthma exacerbations admitted to the emergency department (ED). STUDY DESIGN: We conducted a randomized, noninferiority trial including patients aged 1-14 years who presented to the ED with acute asthma to compare the efficacy of 2 doses of dexamethasone (0.6 mg/kg/dose, experimental treatment) vs a 5-day course of prednisolone/prednisone (1.5 mg/kg/d, followed by 1 mg/kg/d on days 2-5, conventional treatment). Two follow-up telephone interviews were completed at 7 and 15 days. The primary outcome measures were the percentage of patients with asthma symptoms and quality of life at day 7. Secondary outcomes were unscheduled returns, admissions, adherence, and vomiting. RESULTS: During the study period, 710 children who met the inclusion criteria were invited to participate and 590 agreed. Primary outcome data were available in 557 patients. At day 7, experimental and conventional groups did not show differences related to persistence of symptoms (56.6%, 95% CI 50.6-62.6 vs 58.3%, 95% CI 52.3-64.2, respectively), quality of life score (80.0 vs 77.7, not significant [ns]), admission rate (23.9% vs 21.7%, ns), unscheduled ED return visits (4.6% vs 3.3%, ns), and vomiting (2.1% vs 4.4%, ns). Adherence was greater in the dexamethasone group (99.3% vs 96.0%, P < .05). CONCLUSION: Two doses of dexamethasone may be an effective alternative to a 5-day course of prednisone/prednisolone for asthma exacerbations, as measured by persistence of symptoms and quality of life at day 7. CLINICAL TRIAL REGISTRATION: clinicaltrialsregister.eu: 2013-003145-42.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Paniagua N, Lopez R, Muñoz N, et al. Randomized Trial of Dexamethasone Versus Prednisone for Children with Acute Asthma Exacerbations. J Pediatr. 2017. PMID: 29173304. doi:10.1016/j.jpeds.2017.08.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。